About Ready for <800>

Professional Practice Coordinator, Infusion Services

Seth Eisenberg has been practicing in the field of oncology since 1983. His experience includes 28 years in hematopoietic stem cell transplantation at the Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance. He has published numerous articles on chemotherapy and biotherapy, written three book chapters, and presents nationally and internationally at nursing and pharmacy conferences. He has also been the principal investigator in two nursing research studies.

As an active leader within the Oncology Nursing Society (ONS), Eisenberg has served as an ONS Connect contributing editor for five years and as Coordinator for the Chemotherapy Special Interest Group. He served for five years on the Oncology Nursing Certification Corporation’s test development committee, and was recently appointed as Committee Chair to the Bone Marrow Transplant Certification test development committee.

Eisenberg is currently the Professional Practice Coordinator for Infusion Services at the Seattle Cancer Care Alliance Ambulatory Clinic.

President

Eric S. Kastango, MBA, BS Pharm, FASHP, is president of Clinical IQ LLC, a health care consulting firm and CriticalPoint, LLC, a web-based education company.

Kastango received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. He completed 65 hours of training in nuclear pharmacy at Purdue University and 80 hours of didactic training for the Six Sigma-Green Belt certification that he started with BD Medical Systems.

Kastango received a coveted ISMP Cheers Award in 2015 for his work related to sterile compounding safety. He is one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award that recognized his efforts and assistance to the states and NABP to address the compounding tragedy that occurred in 2012.

Since 1980, Kastango has practiced pharmacy in a number of practice settings, including hospitals, community, and home care, and in a number of different of roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed a FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.

He is an active member and Fellow of the American Society of Healthcare Pharmacists and served on the USP Sterile Compounding Committee from 2005-2010 and 2010-2015 USP Council of Experts, Compounding Expert Committee until April 2013. In May 2013, USP recognized Kastango and the members of the Compounding Expert Committee with an Award for Outstanding Contribution to the USP Standards-Setting Process.

Kastango has served on the USP Hazardous Drug Expert Panel since 2010. He is actively working with NABP and state boards of pharmacy to provide training to their sterile compounding inspectors. He served on the Expert Panel for ASHP Research & Education Foundation in the development of the 2015 Outsourcing Sterile Products Preparation Vendor Assessment Tool and ASHP’s Insourcing Readiness Assessment Tool.

Director, Accreditation and Medication Safety and Innovative Delivery Solutions

Patricia Kienle is the Director of Accreditation and Medication Safety for Cardinal Health Pharmacy Solutions. She received her pharmacy degree from the Philadelphia College of Pharmacy and Science, and a Masters in Public Administration from Marywood University in Scranton, Pennsylvania. She completed an Executive Fellowship in Patient Safety from Virginia Commonwealth University and is an Adjunct Associate Professor at Wilkes University in Wilkes-Barre, Pennsylvania.

She has served on the Board of Directors of the American Society of Health-System Pharmacists and as President of the Pennsylvania Society of Hospital Pharmacists. She is a Fellow of the American Society of Health-System Pharmacists, named Pharmacist of the Year by the PSHP, and the recipient of the Distinguished Achievement Award in Hospital and Institutional Practice from the American Pharmaceutical Association Academy of Pharmacy Practice and Management. She has served on the Pharmacotherapy Specialty Council of the Board of Pharmaceutical Specialties, as the pharmacist member of the Hospital Professional and Technical Advisory Committee of the Joint Commission, and on the Board of Governors of the National Patient Safety Foundation. She is a current member of the USP Expert Committee on Compounding, and chair of the Subcommittee and Expert Panel on Hazardous Drugs.

Kienle is the author of Compounding Sterile Preparations: ASHP’s Visual Guide to Chapter <797> video and Companion Guide and co-author of Assuring Continuous Compliance with Joint Commission Standards: A Pharmacy Guide, 8th edition. She edited Understanding JCAHO Requirements for Hospital Pharmacies. She is a frequent presenter to professional groups, with special interests in promoting medication safety, compounding sterile preparations, accreditation and regulatory issues.

President and Chief Executive Officer

Coyne has over 25 years of experience as a healthcare executive with expertise in building or optimizing organizational performance processes and measuring systems and infrastructure to maximize outcomes in national healthcare organizations. He is a skilled strategist who transforms strategic visions into actionable solutions. A motivated self-starter, Coyne brings business acumen and an open-minded, adaptable, hands-on entrepreneurial spirit that produces sustainable results for our clients.

He has served on the board of directors of several national and international organizations. Coyne also has served as an Adjunct Senior Clinical Professor with the Department of Pharmacy Practice at his alma mater The Philadelphia College of Pharmacy and Science where he received his bachelors degree.

Coyne has published numerous articles on the practice of pharmacy and oncology pharmacy management, and has spoken nationally for pharmaceutical companies, group purchasing organizations, and Fortune 100 companies.

Oncology Nurse Specialist

Martha Polovich is an Oncology Clinical Nurse Specialist at Southern Regional Health System in the South suburban Atlanta area. She has been caring for people with cancer and administering chemotherapy since 1980. Polovich has been a trainer and instructor trainer for the Oncology Nursing Society’s Cancer Chemotherapy Course since 1998. She is co-editor of the ONS publication “Chemotherapy and Biotherapy Guidelines and Recommendations for Practice” (2001) and editor of “Safe Handling of Hazardous Drugs” (2003).

Polovich represents the Oncology Nursing Society on the National Institute for Occupational Safety and Health (NIOSH) Hazardous Drug Safe Handling Working Group. She participated in the preparation of the NIOSH Alert “Reducing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings,” which was published online in March 2004 and is available at: www.cdc.gov/niosh/docs/2004-HazDrugAlert/pdfs/2004-HazDrugAlert.pdf.

Medical Director, Occupational Health Services

In her role as medical director, Ellen uses her clinical expertise and management skills to oversee Inova’s Occupational Health Centers ensuring integrated and consistent delivery of care. She will also focus on new program development and improving patient and client satisfaction through process improvement and clinical protocols.

Kessler received her medical degree from Georgetown University and brings over 25 years of occupational health experience and directorship to the program and is board certified in occupational medicine and internal medicine. She has worked with many national and local municipalities and agencies.